Sort
261,768 grants matching “gene therapy”
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans
$1,577,815Robert N Weinreb · University Of California, San Diego · R01 · FY2013 · EY
HSC DIFFERENTIATION
$1,577,448Children'S Hospital Los Angeles · P50 · FY2004 · HL
Clinical and Mechanistic Investigations of Salivary Gland Dysfunction
$1,577,200Blake Warner · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
$1,577,126Jonathan L. Haines · Case Western Reserve University · R01 · FY2023 · AG
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
$1,577,015David Allen Wilcox · Medical College Of Wisconsin · R01 · FY2023 · HL
Genetically-engineered pig organ transplantation in baboons: immunological and functional studies
$1,576,760David Kc Cooper · Massachusetts General Hospital · U19 · FY2024 · AI
Genetically-engineered pig organ transplantation in baboons: immunological and functional studies
$1,576,760David Kc Cooper · Massachusetts General Hospital · U19 · FY2023 · AI
The LIMIting AAA with meTformin (LIMIT) Trial
$1,576,678Ronald L Dalman · Stanford University · R33 · FY2024 · HL
Hematopoietic Stem Cells for Transplantation
$1,576,651Johns Hopkins University · P01 · FY2005 · CA
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE
$1,576,475Baylor College Of Medicine · P50 · FY2002 · HL
Targeting resitin and RELM-beta to treat pulmonary hypertension
$1,576,472Roger A Johns · Johns Hopkins University · UH2 · FY2015 · HL
Immunology of aging and immunotherapy of aging-associated diseases
$1,576,243Arya Biragyn · National Institute On Aging · ZIA · FY2021 · AG
Membrane Remodeling in Viral Infection, Muscular Dystrophy, Parasite Invasion, and Traumatic Brain Injury
$1,576,146Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
Mechanisms of Esophageal Carcinogenesis
$1,576,087Anil K Rustgi · Columbia University Health Sciences · P01 · FY2020 · CA
Inherited Ocular Diseases
$1,575,949James F. Hejtmancik · National Eye Institute · ZIA · FY2014 · EY
Cancer-cell specific therapy: photo-immunotherapy
$1,575,941Hisataka Kobayashi · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Neuron regenerative therapeutic, NNI-362, for first-in-human safety and PK for AD
$1,575,691Judith A Kelleher-Andersson · Neuronascent, Inc. · R01 · FY2018 · AG
HLS- A Phase 1 Open-Label Dose-Escalation with Expansion Study of SX-682 in MDS Patients
$1,575,472Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2020 · HL
Differential activation of the triacylglycerol pathway in lipofibroblasts induces neurogenesis associated with prostate cancer progression
$1,575,170Omar Franco Coronel · Louisiana State Univ Hsc Shreveport · R01 · FY2025 · CA
Strategies to Optimize Pig-to-Primate Kidney Xenograft Survival
$1,575,160Andrew B Adams · University Of Minnesota · U01 · FY2025 · AI
Cellular and Molecular Mechanisms of Vascular Malformations
$1,575,107Sarah Sheppard · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
Development of Innovative Resources to Advance MDS Research
$1,574,993Marie Bleakley · Fred Hutchinson Cancer Center · RC2 · FY2025 · DK
Development of Innovative Resources to Advance MDS Research
$1,574,980Marie Bleakley · Fred Hutchinson Cancer Center · RC2 · FY2023 · DK
The Effect of Serum Psychotropic Drug Levels and Drug Metabolizer Status on Delirium Duration and Long-term Cognition
$1,574,743Jin Ho Han · Vanderbilt University Medical Center · R01 · FY2025 · AG
Optimizing Ridaifen-B analogs as potential therapeutics for Ebola viruses
$1,574,644Lijun Rong · University Of Illinois At Chicago · R01 · FY2025 · AI